bioAffinity Technologies, Inc. (BIAF): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

An assessment of the projected EPS dynamics for the coming year demonstrates the potential of bioAffinity Technologies (BIAF), where the current mark equals 0.00. Growth is driven by leadership in non-invasive oncology detection via AI-powered sputum analysis. Business stability is guaranteed by operating within the US jurisdiction without external pressure. Future financial success will rely on the mass adoption of the CyPath Lung diagnostic test.

BIAF: Prakiraan wutah bathi resik saben saham kanggo taun ngarep bioAffinity Technologies Inc. 28.04.2023 - 11.11.2026

Rincian metrik lan analitis perusahaan bioAffinity Technologies, Inc. (BIAF)

- rega saham lan konsensus proyeksi valuasi:

Rega saham bioAffinity Technologies Inc.|BIAF - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Nilai pasar bioAffinity Technologies|BIAF - Nilai Dipunlarasaken Utang lan Kas

- rincian nilai buku perusahaan:

Nilai Buku saben Saham bioAffinity Technologies|BIAF - Nilai Buku Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku bioaffinitytech.com|BIAF - Gunggung Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Utang marang Ekuitas bioAffinity Technologies|BIAF - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal bioAffinity Technologies Inc.|BIAF - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku bioAffinity Technologies|BIAF - Kewajiban jangka dawa|Utang jangka cendhak perusahaan bioAffinity Technologies|Rasio cepet bioaffinitytech.com

- informasi bathi lan kelipatan valuasi:

BIAF - Asil keuangan resik|Bathi sing dikarepake bioAffinity Technologies|BIAF - Pangali rega marang bathi|Pangali Forward P/E bioAffinity Technologies Inc.|BIAF - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan bioAffinity Technologies|BIAF - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan bioAffinity Technologies|BIAF - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan bioaffinitytech.com|BIAF - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep bioAffinity Technologies

Analisis dhasar perusahaan:bioAffinity Technologies, BIAF

Barang utama bioAffinity Technologies, Inc.

To filter for high-quality assets, investors must distinguish market noise from the actual growth potential of net income. This metric measures the trend of expert earnings per share (EPS) expectations, which in the case of bioAffinity Technologies (BIAF) reflects the commercial success of integrating diagnostic systems into mandatory medical protocols, confirming steady demand for consumables via the projected EPS growth benchmark.

Karo sapa bioAffinity Technologies saingan

AVBP (ArriVent BioPharma, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Lantern LTRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep eFFECTOR Therapeutics (EFTR)